GLP-1 Lab Work: What Your Doctor Should Be Monitoring

A GLP-1 prescription without ongoing lab monitoring is like driving without a dashboard — you might be fine for a while, but you're missing critical information that could prevent a serious problem. Regular blood work during GLP-1 therapy isn't optional; it's part of responsible medical care.

Here's exactly what your provider should be testing, when they should be testing it, and what the results mean for your treatment.

Baseline Labs (Before Starting Treatment)

Before your first injection, your provider should order or review recent results for:

Comprehensive Metabolic Panel (CMP)

This single panel captures several critical baselines: kidney function (BUN, creatinine, eGFR), liver enzymes (AST, ALT), blood glucose, and electrolytes. These values establish your starting point so any medication-related changes can be detected early.

HbA1c

Your three-month blood sugar average. Even if you're not diabetic, A1c establishes where your metabolic health stands before treatment. Many non-diabetic GLP-1 patients have pre-diabetic A1c levels (5.7–6.4%) that improve with treatment — tracking this is motivating and clinically valuable.

Lipid Panel

Total cholesterol, LDL, HDL, and triglycerides. GLP-1 medications often improve lipid profiles — particularly triglycerides — and documenting the baseline makes the improvement visible at follow-up.

Thyroid Panel (TSH at Minimum)

Because of the boxed warning regarding thyroid C-cell tumors, baseline thyroid function is essential. TSH (thyroid-stimulating hormone) is the standard screening test. If TSH is abnormal, your provider will order free T3 and free T4 for a complete picture. Calcitonin testing may be appropriate if there's any family history of medullary thyroid carcinoma.

During Titration (Months 1–6)

Month 3 Labs

At the 3-month mark, your provider should recheck:

• Kidney function: GLP-1 side effects (nausea, vomiting, diarrhea) can cause dehydration that stresses the kidneys. An early check catches any declining function before it becomes a problem.
• Liver enzymes: Rare cases of elevated liver enzymes have been reported with GLP-1 medications. A 3-month check establishes whether values are stable.
• A1c: Particularly important for diabetic and pre-diabetic patients — you'll likely see improvement, and your provider may need to adjust other diabetes medications to avoid hypoglycemia.

Month 6 Comprehensive Panel

At 6 months, order the full panel again:

• CMP (kidney, liver, electrolytes, glucose)
• Lipid panel
• A1c
• TSH
• Vitamin B12 (GLP-1 medications can affect B12 absorption over time)
• Vitamin D (weight loss can affect vitamin D levels)
• Iron and ferritin (particularly for women and patients on calorie-restricted intake)

Ongoing Monitoring (Every 6–12 Months)

Once you're on a stable dose, labs should be repeated every 6–12 months. The interval depends on your individual risk factors:

• Every 6 months: Patients with pre-existing kidney disease, diabetes, or liver conditions
• Every 12 months: Generally healthy patients on a stable dose with no concerning trends

What the Numbers Mean for Your Treatment

Kidney Function (eGFR, Creatinine)

If eGFR drops significantly or creatinine rises, your provider should assess for dehydration first (the most common cause) and consider slowing or pausing treatment. In rare cases, GLP-1 therapy may unmask or worsen underlying kidney disease.

Liver Enzymes (AST, ALT)

Mild elevations (less than 3x the upper limit of normal) are generally monitored. Significant elevations warrant further investigation and potentially discontinuing the medication. Good news: many patients with fatty liver disease (MASLD) actually see liver enzymes improve on GLP-1 therapy.

Thyroid (TSH)

Stable TSH is reassuring. A significant change — particularly a suppressed TSH — may prompt further thyroid evaluation. Your provider should be aware of any new neck swelling, difficulty swallowing, or hoarseness.

A1c Improvements

Expect A1c reductions of 0.5–1.5% or more over 6 months, depending on your starting level. If you're on insulin or sulfonylureas, your provider must adjust those medications as A1c drops to avoid dangerous hypoglycemia.

Lipid Changes

Triglycerides often drop significantly. LDL may decrease modestly. HDL may increase. These improvements reduce cardiovascular risk — a major secondary benefit of GLP-1 therapy beyond weight loss.

If Your Provider Isn't Ordering Labs

This is a real problem — and it's more common than it should be. If your GLP-1 provider has never ordered lab work or hasn't requested it in over 6 months, bring it up directly: "I'd like to get routine monitoring labs. Can you order a CMP, A1c, lipid panel, and TSH?"

If your telehealth provider doesn't offer lab ordering, you can get these through your primary care doctor, a direct-to-consumer lab service (Quest, LabCorp), or an at-home lab kit. The tests themselves are standard and widely available. What matters is that someone is reviewing the results and adjusting your treatment accordingly.